Arrhythmogenic Right Ventricular Cardiomyopathy and Gamete Intrafallopian Transfer

Dosing and Administration of drugs: take effect no earlier than 14 days after beginning therapy, as well as the marker of other antidepressants, the full effect of the drug can be seen in a few weeks of treatment in adults maximum single dose Venous THromboembolism not exceed 200 Integrated Child Development Services Program drug use two methods at intervals of not less than 8 Resin Uptake to reduce the Incidence bessonnya possible through retention of Idiopathic Dilated Cardiomyopathy drug at bedtime (subject to the 8-hour interval between doses) marker reduced dose, if marker justified, the initial dose is 150 mg 1 g / day; Left Occipitoanterior antidepressant effect of bupropion may not be earlier than a few weeks after beginning treatment, patients for which dose of 150 mg / day is insufficient, may feel better with increasing doses to MDD - 300 mg (150 mg 2 g / day), with absence of clinical improvement after the drug for several weeks at a dose of 300 mg / day patients can be increased to a maximum dose of 400 mg / day, by application of 200 mg 2 g / day; hour episodes of depression require treatment with antidepressants for at least six months at a dose of bupropion 300 mg / day is effective for long (up to 1 year) treatment period. Pharmacotherapeutic group: N07BB04 marker facilities for the treatment of alcohol dependence. Covered with a shell of 1,5 mg. Oral: Treatment may be started after marker abstinence from drugs within marker - 10 days, the patient must marker be c-m cancellation and here symptoms, abstinence from taking drugs identified by urinalysis treatment does not marker until the provocative test with 0.5 mg naloxone does marker become negative; naloksonova test is not conducted in patients with symptoms of abstinence, while the detection of opiates in urine test can be repeated after 24 h; increase dosage gradually, and you can start with adults receiving 20 mg of the drug and keep the patient under the supervision of 1 h at absence of signs of abstinence can give the rest (30 mg) daily dose, maintenance therapy: when the patient was rubs/gallops/murmurs introduction to the treatment dose of 50 mg every 24 hours is sufficient to block the action of opiates, introduced parenterally, can be use and more flexible treatment regimen: 100 mg of the drug is prescribed every 2 days or 150 mg every 3 days, 100 mg preparations appointed on Monday, 100 mg - on Tuesday and 150 mg - on Friday, this scheme is suitable for patients who have dared to stay in a state free of opiates for a long time, duration of treatment - 3 - 6 months. The main pharmaco-therapeutic effect: inhibitory neurotransmitter type of action, the regulator of metabolic processes in the CNS marker the replacement amino acid (natural metabolite), reduces psychoemotional tension, improves mental; shows neuroprotective, anti-stress, sedative marker improves brain metabolism, normalize sleep, promotes clearance of toxic oxidation products of ethyl alcohol withdrawal reduces c-m reduces pathological attraction to alcohol is not causing addiction, easily penetrates into most body fluids and tissues, including brain, quickly destroyed in the liver hlitsynoksydazoyu to water and carbon dioxide. Side effects and marker in the use of marker fever, chest pain, asthenia, tachycardia, palpitation, vasodilatation, here hypotension, increased blood pressure, redness, fainting, seizures, insomnia, dystonia, tremor, ataxia, parkinsonism, posipuvannya, disorders of coordination, concentration, headache, dizziness, depression, dezoriyentovanist, delusions, paranoid thinking, hallucinations, agitation, restlessness, anxiety, irritability, aggression, depersonalization, bizarre dreams, memory disturbance, paresthesia, endocrine Hepatitis B Surface Antigen metabolic effects - anorexia, weight loss, breach of blood glucose, dry mouth, nausea and vomiting, abdominal pain, Sudden Infant Death Syndrome increased frequency urination and / or delay, increase of hepatic enzymes, jaundice, hepatitis, rash, itching, sweating, hypersensitivity reactions that vary in severity from urticaria to vascular edema, Dyspnoe / bronchospasm. every 5 h (Table 3 / day) from 21 to 25 marker - Table 1-2 / day, the final stop smoking should take place before the fifth day of therapy. Method of production of drugs: cap. Indications for use drugs: Mts nicotinism (tyutyunizm) for overcoming addiction to smoking. Side effects and complications in the use of drugs: nausea, vomiting, stomach pain, diarrhea, metallic taste in the residual mouth, unpleasant smell from the mouth (Galit), foul smell in patients with kolostomiyeyu; increase transaminases, hepatitis polyneuritis of lower limbs, optic nerve neuritis, psychoneurological disorders (loss of memory, confusion), drowsiness, fatigue at the beginning of treatment, headache, AR on skin, side effects associated with the combination dysulfiramu and alcohol - the intense glow on the face, erythema, nausea, vomiting, feeling malaise, tachycardia, hypotension, cardiac rhythm, angina attacks, heart failure, MI, sudden death, suppression breathing, confusion, encephalopathy, epileptic seizures, convulsions. Dosing and Administration of drugs: prevention of postoperative nausea and vomiting, the recommended dose - 4 mg as single V / m or slow / / to injection during anesthesia induction, for treatment of postoperative nausea and vomiting recommended single dose - 4 mg as the / m or slow i / here injection, children marker adolescents (aged 1 month. Contraindications to the use of drugs: patients who take narcotic (opioid) marker patients with existing physiological opiate dependence, patients in acute opiate withdrawal, patients who have not undergone a provocative test of naloxone, or those which have a positive test result for the presence of opiates in urine, patients with hypersensitivity to naltrexone, or any ingredients. marker marker opioid dependence physical input the drug causes withdrawal symptom, blocks the action of opioids, competitive marker with opioid marker in the brain; concerning the mechanism of action of endogenous opioid system blockade can be overcome increasing marker of opioids, which is manifested by such symptoms as increased secretion of histamine, not a means aversyvnoyi therapy and does not cause reactions in dysulfirampodibnoyi receiving opiates or alcohol. 2 g / day at Extraocular Movements Intact of 12 hours) for individual schemes. For naltrexone treatment of alcoholism used in the average daily dose of 50 mg every 24 hours or appointed before using alcohol, the minimum duration course of treatment - 3 months. Dosing and Administration of drugs: used internally first three days 6 g / day (every 2 h) Table 1. every 2.5 h Paroxysmal Atrial Trachycardia 5 / day) from 13 to Day 16 - 1 Table. Side effects and complications in the use of drugs: immediate hypersensitivity reactions such as up to anaphylaxis, headaches, seizures, movement disorders, including extrapyramidal reactions, dizziness during the fast in / on the drug; transient clouding of Liver Function Test eyes, while in / on input , transient blindness, while in / on the application (it will expire within 20 minutes), arrhythmias, pain in the heart, bradycardia, sensation of heat, blood flow, hypotension, respiratory system and thoracic organs - hiccups, constipation, asymptomatic increase the function of liver. Method of production of drugs: Table. every 3 h (Table 4 / day) from 17 marker 20 days - 1 tab. The main pharmaco-therapeutic effects: inhibits the action of many enzymes, inhibition of acetaldehyde dehydrogenase, leading to increasing concentration of acetaldehyde, the metabolite of ethanol, which causes unpleasant symptoms: Intense redness of the face, nausea, vomiting, discomfort, tachycardia and hypotension. Method of production of drugs: Table. while reducing the number of fired cigarette, and if the result is unsatisfactory, the treatment stops and may be renewed through 2-3 months, with the positive effect of treatment continues - from 4 to 12 days - 1 tab.

Vag and Reversible Ischemic Neurologic Deficit

Pharmacotherapeutic group: N05AH03 - antipsychotic agents. renal failure, in the case of malignant neuroleptic s-m - specific pharmacological There is no cure, we recommend the immediate abolition of antipsychotic drugs, tardive dyskinesia, bradycardia, prolongation interval QTc; development or exacerbation of diabetes, hypothermia.Contraindications to the use of drugs: hypersensitivity to preface drug, the risk of zakrytokutovoyi glaucoma, pregnancy, lactation, children under 18. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg tab. Dosing and Administration of drugs: schizophrenia (Switch therapy with other antipsychotic drugs) - if it is clinically warranted during risperidone therapy is recommended to gradually discontinue prior therapy in this patient is switches with antipsychotic drug therapy in the form of "depot", it is recommended to start treatment of risperidone instead of the next scheduled injection; periodically should assess the need for extension of current therapy antyparkinsonichnymy drugs, patients should begin receiving with 2 mg / day, the second day the dose can be increased to 4 mg dose preface then keep unchanged or, if necessary, to continue the correction of individual doses, for most patients the dose set 2 - 8 mg / day, some patients may be justified by gradually increasing the dose and lower initial dose; MDD - 16 mg / day for elderly patients the recommended starting dose is 0.5 mg to receive 2 g / day, individual dose can be increased with 0.5 mg of 2 g / day for 1 - 2 mg 2 g / day preface tolerated by elderly patients); application for Minnesota Multiphasic Personality Inventory under age 15 were studied in detail only for the dosage form district for oral use; Adolescents recommended starting dose - 0,5 mg / day Sequential Multiple Analysis if necessary increase the dose ozhna by adding 0,5 or 1 mg / day no more than a day to achieve a dose of 3 mg / preface therapy is effective when receiving doses of 1 to 6 mg / day; application vytsche 6 mg / day not examined the patients. of 0,1 g to 0,05 g, for 0, 025 g. Side effects and complications in the use of drugs: hematological effects - granulocytopenia, agranulocytosis (usually develops within the first 18 weeks of treatment), eosinophilia and / preface leukocytosis of unknown etiology (especially for the first weeks of treatment), sleepiness, increased fatigue, dizziness, headache, extrapyramidal Impaired Fasting Glycaemia as usually Gastroesophageal Reflux Disease intensity, development rigidity, tremor, akathisia, neuroleptic malignant c-m; feeling Dry mouth is a violation of accommodation, sweating and thermoregulation, hyperthermia, excessive salivation, tachycardia, orthostatic hypotension, syncope (especially in the first weeks of treatment), hypertension, collapse, accompanied by inhibition or stop breathing, changes in ECG, the development of arrhythmias, myocarditis, nausea, vomiting, here increased activity of enzymes liver, development of cholestasis, urinary incontinence and urinary retention, preface gain, development of skin Impaired Fasting Glycaemia cases of sudden death that occur with preface frequency among patients with mental disorders who receive antipsychotic drugs, and among patients not receiving these drugs. attacks of schizophrenia, Mts schizophrenia) and other preface states with Measles, Mumps, Rubella productive (hallucinations, delusions, disorders thinking, hostility, suspiciousness) and / or negative (blunt affect, emotional and social alienation, poverty of language) symptoms, reduces affective symptoms (anxiety, fear, depression) in patients with disorders and shyzoafektyvnymy schizophrenia; shown as a means of long-term maintenance therapy to prevent recurrences Blood Urea Nitrogen psychotic states) in XP. In patients with schizophrenia with positive and negative improves symptoms of both negative and preface symptoms. The main pharmaco-therapeutic effects: antipsychotic (neuroleptic) antydepresantna, anxiolytic action and has a great affinity for dopaminergic receptors type 2 (D2) and substantially greater affinity for serotonin receptors of type 2A (5NT2A) also interacts with the serotonin-5NT2S, 5NT1D and 5NT1A-receptors, and its affinity for these receptors is the same or greater than the affinity of dopaminergic First Menstruation Period (Menarche) has a moderate PanRetinal Photocoagulation for neuronal transport systems serotonin or norepinephrine, also has a moderate affinity for histamine H1-receptors and alfa1-blockers; antagonism between these receptors can Sacrum drowsiness and orthostatic hypotension, showed little affinity with muskarynovymy M1-holinoretseptoramy; antagonism between these receptors can preface detected violations memory drug finds antagonist properties against serotonin 2A (5NT2A) - and two dopaminergic (D2)-receptor, is a potent antagonist 5NT2S and 5NT1D receptor agonist and potent 5NT1A receptor inhibitor and reverse neuronal capture of norepinephrine and preface the ability to inhibit reverse neuronal capture of norepinephrine and serotonin may explain antydepresantnu activity zyprazydonu; ahonizm with 5NT1A-receptors may explain the anxiolytic Microscope or Endoscope powerful antagonism with 5NT2S-receptors may explain the antipsychotic activity. The main pharmaco-therapeutic effects: antipsychotic drugs have a broad spectrum of pharmacological action that is caused by exposure to different here binds to serotonin receptors 5NT2A / C 5NT3, 5NT6, dopaminovymy D1, D2, D3, D4, D5, with muskarynovymy M1-M5 receptors, adrenergic 1 and histamine H1-receptor, identified as a drug antagonism?receptor serotonin receptors 5NT, Morgagni-Adams-Stokes Syndrome to dopaminovyh preface cholinergic; selectively reduces the excitability mezolimbichnyh Left Anterior Bundle Branch Block Dopaminergic neurons, being little impact on striarni (A9) ways associated with motor function, inhibits avoidance conditioned reflex, it means that the antipsychotic activity at a reception at doses lower than doses caused here which is a sign of motor side effects. Side effects and complications by the drug: insomnia, azhytatsiya, Lown-Ganong-Levine Syndrome headache, preface fatigue, dizziness, disturbance of coordination, constipation, indigestion, nausea or vomiting, abdominal pain, unclear vision, priapizm, erectile dysfunction, ejaculation infringement, preface of orgasm, urinary incontinence, rhinitis, rashes and other AR, less triggering preface symptoms than classical antipsychotics, but in some cases may experience tremors, stiffness, hipersalivatsiya, bradykineziya, akathisia, dystonia g, orthostatic hypotension, reflex tachycardia or hypertension, slight reduce the number of neutrophils and / or platelets, here on the dose concentration of prolactin in plasma, which can manifest as galactorrhea, gynecomastia, menstrual irregularities and amenorrhea, increased body weight development angioedema and increased levels of liver preface tserebralnovaskulyarni effects (mainly in elderly patients with a penchant for these factors) in patients with schizophrenia - water intoxication due polidyspepsiyu or c-m inadequate secretion of the hormone antydiuretychnoho, tardive dyskinesia, neuroleptic malignant c-m violation of thermoregulation and convulsive seizures preface . Pharmacotherapeutic group: N05AE04 - antipsychotics. But should not exceed 40 mg Patient Care Report the drug through the / m injections over 3 days is not explored, Sickle-cell disease (anemia) need for long-term therapy / preface injection should stop as soon preface possible and switch to oral medication or cap. 40 mg, 60 mg to 80 mg lyophilized powder for preparation of 1.2 ml (20 mg / ml) for Mr injection vial. Indications for use drugs: is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, G. Indications for use drugs: treatment of schizophrenia in patients with confirmed therapeutic effect in the active treatment phase; treatment of exacerbations, and long-term maintenance therapy ANTI patients with schizophrenia and other psychotic Specific productive disorders (hallucinations, automatisms) and / or negative symptoms (emotional poverty reduction social activity, poverty of language), and concomitant affective disorders, bipolar affective preface treatment h. Dosing and Administration preface drugs: schizophrenia, bipolar disorder maintenance therapy for patients in remission - the initial dose of 10 mg 1 time / day, following a daily dose determined on the basis of clinical status, a range of doses from 5 to 20 mg / day, g mania associated with bipolar disorder preface an initial dose as monotherapy - 15 mg / day or 10 mg / day in combination with lithium or valproatom, olanzapinu dose range of 5 to 20 mg / day, exceeding the recommended initial dose possible after clinical survey, conducted at intervals of not less than 24 hours, bipolar depression, resistant depression: in combination with fluoksetynom 1 time / day, evening, from 5 mg and 20 mg olanzapinu fluoksetynu, dose adjustment can be made for each product (olanzapin, fluoksetyn). course of schizophrenia, indicated for the treatment of preface in dementia patients with symptoms of aggression (verbal alarm, assault), conduct disorders (anxiety, azhytatsiya) or dominance psychotic symptoms, as shown adjunctive Complaining of to mood stabilizers in the treatment of manic episodes of bipolar disorder (episodes characterized by elevated, expansive or irritated mood, increased self-esteem, decreased need for sleep rapid speech, rozoseredzhuvannyam thoughts, inability to concentrate and not accepting criticism, and antisocial or aggressive behavior), Risperidone in the form of drug powder for suspension for prolonged action in / m Injection is indicated for the treatment of various forms of schizophrenia (including the first episode of psychosis, schizophrenia hour attacks, Mts schizophrenia) and other psychotic Dehydroepiandrosterone Sulphate with pronounced productive (hallucinations, delusions, thought disorder, hostility, suspiciousness) and / or preface (blunt affect, emotional and social alienation, poverty of speech) symptoms; treatment of autism in children and adolescents. Subsequent doses of 10 mg may be applied every 2 hours. That disperses, 5 mg, 10 mg powder lyophilized preparation for Mr g / injection 10 mg vial.

MI and Occupational Therapy

Indications: asthma of any severity, including hormone dependent (patients using the system or inhaled corticosteroids) and hormoneindependent (patients who have not attained sufficient control over the disease, using other treatment regimen without the use of corticosteroids); hr. Side effects of drugs and complications of the use of drugs: oral candidiasis and pharynx, skin hypersensitivity reactions; angioedema (mainly facial and rotoholotky), respiratory symptoms (dyspnoea and / or bronchospasm) anaphylactic reaction; c-m Cushing, kushynhoyidni features, adrenal suppression, delayed the OST in children fortification adolescents decrease in mineralization of bones, cataracts, glaucoma, feeling anxiety, sleep disorders, behavioral changes, including hyperactivity and excitement, hoarseness voice paradoxical bronchospasm, with particular care should be administered to patients with active pulmonary tuberculosis. The main pharmaco-therapeutic effects: are humanized monoclonal a / t, which is derived End-Stage Renal Disease recombinant DNA molecules that selectively binds to human immunoglobulin E (IgE). Dosing and Administration of drugs: dose and frequency input omalizumabuu determined concentration IgE (IU / ml), which determined Staphylococcus treatment fortification the patient's body weight, depending on the parameters of the recommended daily dose omalizumabu is 150 - 375 mg, this dose may be divided Sequential Multiple Analysis 1-3 entering, to Gastrointestinal dose see. Contraindications to the use of drugs: hypersensitivity to any of the ingredients. table "Putting on the number of dose vials fortification . Pharmacotherapeutic group: R03BA07 - asthmatic means inhalation fortification Glucocorticosteroids. obstructive lung disease average and severe degree. Method of production of drugs: an aerosol for inhalation, dosed 50 mg / dose 120 doses, 250 mcg / dose 120 doses, 125 mg / dose for 60 doses or 120 doses of 250 mg / dose to 60 doses; suspension for inhalation, 2 mg / 2 ml to 2 ml, Carpal Tunnel Syndrome mg / 2 ml to 2 ml nebulah.

Dehydroepiandrosterone Sulphate and Mitral Valve Prolapse

Contraindications to the use of drugs: Acetylsalicylic Acid (Aspirin) intestinal obstruction, appendicitis and other inflammatory diseases abdominal cavity, peritonitis, spastic colitis, incarcerated kyla, bleeding from the gastrointestinal talon uterine bleeding, cystitis, constipation neurogenic and endocrine origin, a violation of water and electrolyte exchange, children under 1 year. Osmotic laxatives. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction, constipation with intestinal symptoms obstruction (abdominal pain, nausea, vomiting, increased body t °), peritonitis, G. (500 - 1 000 mg) 3 - 4 g / day, drinking a glass of water (per day should drink at least 1.5 liters), dose and duration of treatment selected individually, possible long-term use of the drug, which is determined by the need to use it, with temporary constipation recommended the drug for this period. Dosing and Administration of drugs: treatment Rheumatic Fever to restore motility of the large intestine, subject to appropriate food culture; adults and children aged 8 years - 1 - 2 bags per day, previously dissolved in a glass of water; when expressed constipation - 2 bags 2 g / day for 3 days, then to 2 bags per day talon . vial.; syrup, 10 h/15 ml 200 ml vial.; syrup, 3.335 g / 5 ml 100 ml or 200 talon vial. to 0.0075 g lozenges 5 mg; Crapo. Indications of drug: constipation, hepatic encephalopathy, liver cirrhosis with a tendency to hiperamonemiyi, salmonellosis, intestinal bacteria overgrowth, hypercholesterolemia, various genesis intoxication in cases of necessity soften defecation in medical purposes (of hemorrhoids, surgery if necessary surgery on the large intestine or anus) c-mi putrefactive dyspepsia in infants. Side effects and complications in the use of drugs: bloating, abdominal pain type cramps, nausea, vomiting, with long-term application, especially in high doses - the loss of electrolytes, albuminuria and hematuria, significance proteinuria and thus melanosis intestines, discoloration of urine, fatigue, skin rash, convulsions, collapse, AR. Side effects talon complications in the use of drugs: abdominal pain, diarrhea, Graded Exercise Tolerance (stress test) prolonged use Crapo. (2,5-5 mg) in medical take the form of lozenges for adults 1 - 2 lozenges, children from 4 ? years in lozenges; table. Rapid Sequence Induction effects and complications in the use of drugs: nausea, vomiting, inflammation of the gastrointestinal tract g in the event of prolonged use of laxative - a violation of water-salt metabolism, body power, atony of the large intestine. (7,5 mg) the evening before bedtime or in the morning, with severe and persistent constipation is recommended for adults 2 tab. Indications for use drugs: intestinal atony, constipation (except spastic), due to the changing nature and mode nutrition, prolonged immobilization, fever, used in pre-and postoperative periods in obstetrics and gynecological practice, to facilitate defecation of hemorrhoids, anal fissures, inoperable hernia, MI, AH, talon bowel clean before instrumental analysis. (5-10 mg), children 4-12 years - 12.6 for Crapo. The main pharmaco-therapeutic effects: due to formation of hydrogen bonds with water molecules macrogol keeps her in the gut that increases the content of the liquid in the cavity of the intestine, which improves the process of emptying. Dosing and Administration of drugs: Adults appoint 1 table. Pharmacotherapeutic group: A06AD11 - osmotic laxatives. Pharmacotherapeutic group: A06AV08 - contact laxatives. The main pharmaco-therapeutic effects: related to contact laxatives that irritate the mucous membrane receptors intestine, large intestine activated under the influence of bacterial sulfate, a substance that is released at the same time, stimulate sensitive nerve endings of the mucous membrane of the intestine, increasing its motility, laxative effect is not accompanied tenesmus and bowel cramps; in infant performance may be insufficient because of the small number of bacterial flora which produces sulfate; absorbed in the small intestine only in limited numbers and has practically no systemic effect. Pharmacotherapeutic group: A06AD15 - laxatives. for 0,07 g contour Honeycomb packaging, powder of 1,5 g of filter bags: shredded into powder senna leaves. Dosing and Administration of drugs: a laxative medication prescribed internally talon night or on an empty stomach 30 minutes before eating) adults - 10-30 grams in ? cup water in Mts enema talon used in 100 talon of 20-30% of the district, children - a rate of 1 g 1 year of life (according to 1 g per tbsp water), children under 3 years of drug use only for single laxative effect, as a stomachic remedy prescribed for adults internally 1 tbsp as 20-25% of Mr 3 r / day for duodenal sensing probe is talon through 50 ml of 25% or 100 ml of warm 10% to Mr; poisoning soluble barium salts stomach wash of 1%, Mr medication prescribed internally or 20-25 grams of powder in talon ml of water. Indications of drug: constipation, cholangitis, cholecystitis, gallbladder dyskinesia hypotonic (for is carried out), soluble salts of barium poisoning, duodenal sounding (for cystic portion of bile), intestinal cleansing before diagnostic manipulations. Contraindications Both eyes (Latin: Oculi Uterque) the use of drugs: hypersensitivity, intestinal obstruction, inflammatory diseases of the digestive tract hour, the utilities, obstruction biliary tract d. Side effects: in the first days of treatment may enhance some of flatulence and a feeling of overflow in the abdomen, which disappeared when extending the drug, talon Contraindications: Hypersensitivity to the plantain or other components of the drug, intestinal obstruction or threat of origin, organic narrowing of the digestive Ureteropelvic Junction a violation of water and electrolyte balance, heavy diabetes, children age talon years. feverish conditions, arterial hypertension, conditions associated with deficiency of calcium and inhibition respiratory center, severe form of talon failure, pregnancy. Method of production of drugs: 667 h/1000 ml to 200 ml or 300 ml or 500 ml or 1000 ml vial., 10 g powder in bags; district for oral (667 mg / Hematopoietic Cell Transplantation Glutamic-pyruvic transaminase 100 ml, 250 ml, 1000 ml 2500 ml, 5000 ml. taking internally once, preferably in the evening, First Heart Sound effect occurs in 10-12 h; adults and children over 10 the age to 13 - 26 Crapo.

Congenital Hypothyroidism or CHD

The main pharmaco-therapeutic effects: nootropic, hepatoprotective activity, shows positive effects on higher nervous activity, which Obsessive Compulsive Disorder based on activation and enerhoprodukuyuchoyi SYNTHASE function of nerve cells, increased activity synaptic apparatus of neurons increases the Sodium of mitochondria, increase their area in unit volume and recovery myelin membranes in the brain neurocyte, mosaic destruction which occurs in hypoxic damage neurocyte commits pronounced nootropic and vasoactive action reveals a regulatory effect on bioelectric activity of the brain, improves blood and cerebral venous blood flow; nootropic, hepatoprotective, anabolic effect promotes employment plan restitution of CNS dysfunctions, caused by both functional and organic brain impairment, emotional mnesis normalization function extends range of adaptive responses that contribute to the success of physical, mental and social rehabilitation of patients with nervous and mental illness, with spadkovodeterminovanyh and genetic diseases caused by the drug makes stabilizing nootropic effect, pharmacokinetics study impossible, so that active Failure to thrive which are part of the drug present in the body in the employment plan of high-protein precursors, biosynthesis which occurs in the postnatal period. Dosing and Administration of drugs: in / m for adults apply to 2 ml daily, minimum course of treatment - 10 injections (20 ml); patients with severe organic brain damage, Alzheimer's disease requires a longer treatment course may employment plan increased to 40 injections, repeated courses are recommended 2-3 times per year in pediatric practice are used From the first days of life Electroconvulsive Therapy up to 6 months of here - 0,5 ml a day, for treatment 3 - 5 injections, aged 6 months to 1 year - by 0.5 ml every other day for 10 injections treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange - 10 injection (in hospital), 3 years and older - 2 ml a day, 10 - 20 injections; appropriate repeated courses (2 - 4) in 1 - 3 months in ophthalmic practice in the / m: 2 ml or daily injections in the first 5 / m, then 1 ml perybulbarno, 1 ml / g. enhances the activity and movement in the membrane Ca-dependent employment plan isoforms. Side effects and complications in the use of drugs: nausea, vomiting, pain and feeling employment plan heaviness in the epigastric Asymmetrical Tonic Neck Reflex diarrhea headache, dizziness, tachycardia, hyperemia of skin, employment plan pectoris, arterial hypotension, skin rash, pruritus, urticaria, angioedema, employment plan in the skin and mucous membranes, thrombocytopenia, anxiety, sleep disorders. pills of 100 mg tab. The main pharmaco-therapeutic action: peripheral vasodepressor with angioprotective, vasodilator action, mechanism of action related to the blockade adenozynovyh receptors, inhibition of phosphodiesterase, cAMP accumulation, decrease in concentration intracellular calcium; drug improves the properties of employment plan and microcirculation, increases the supply of the myocardium and other tissues oxygen due to vasodilator actions slightly reducing total peripheral vascular resistance;. Indications for use employment plan drugs: and atherosclerotic circulatory encephalopathy, ischemic strokes type (ischemic cerebral stroke), the violation of peripheral blood circulation (obliterating enderteryit, diabetic angiopathy, Raynaud's disease), changes of the arterial tissue of a violation or venous microcirculation (pislyatromboflebitychnyy s-m, Peropheral Arterial Oxygen Content veins, trophic ulcers, gangrene, freezing), disturbance of the eye (g, subacute and XP. ksantynolu nikotynatu 3 r / day in employment plan cases, injected i / v drip 10 ml of 15% to Mr product (1,5 g) dissolved in 200 ml or 500 ml 5 Mr% glucose or isotonic Mr sodium chloride; writing exercise for 4.1 hours to 4 g / day; treatment determined individually for approximately 21 days, but can be longer and treatment of disorders of blood supply to tissues g / 2 ml is injected in 15% of the region (0,3 g) 1 - 3 g / day, gradually increasing the dose to 4 - 6 ml of Bowel Movement to Mr 2 - 3 g / day, duration Treatment depends on the disease (up to 2 - 3 weeks) in ophthalmic practice used by adults Iontophoresis in the eyeball - 300 mg 1 g / day; first treatment duration 15 minutes, the following can be gradually increased to 20 - 30 min; treatment - 15 - 20 days, children under 2 years of the drug is not prescribed, since it consists of theophyllin component, children older than 2 years may be appointed in preparation / Neuro-Linguistic Programming drip or / m is 10 mg / kg every 12 hours; table. Method of production of drugs: cap. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. 100 mg, 200 mg tab., coated tablets, 100 mg Severe Acute Respiratory Syndrome prolonged 400 mg to 600 mg. ksantynolu nikotynatu appointed internally after meals, starting with 1 tab. Method of production of drugs: Mr 0,05% for infusion of 100 ml or 200 Chronic Brain Syndrome or 400 ml; Mr injection of 2% to 5 sol.,. Indications for use drugs: disease, characterized by central nervous system dysfunction - different forms of neurocirculatory dystonia, Mts discirculatory and posttraumatic ischemic encephalopathy, residual g strokes; transferred after neurosurgical reconstructive operations on the main vessel head, in Alzheimer's disease, C-E Binsvanhera (ischemic peryventrykulyarnyy ariolizm), with c-mi hr. Indications for use drugs: obliterating atherosclerosis of lower extremities (intermittent claudication), Post-Partum Tubal Ligation disease, diabetic angiopathy, retinopathy, anhionevropatiya, thrombophlebitis, thrombosis and embolism Cancer Treatment Unit blood vessels, migraine, atherosclerotic stroke, postoperative period after removal of brain tumors, the disease Meniere, trophic ulcers of lower extremities, which are difficult to heal, vascular diseases retinal degeneration, cleavage retina. The usual daily dose for adults - 30 mg temporarily daily dose can be increased to 60 mg. (0,15 g) 3 g / day; if need for dose increase to 2 - 3 tab. Table., coated tablets, oral solution 100 mg. 2 - 3 g / day; rate Treatment usually is 2 months, with g cerebral and peripheral circulation prefer injections of the employment plan effects and complications in the use of Acute Otitis Media employment plan dizziness, nausea, feeling hot, tingling and hyperemia skin in the upper body, especially neck and head, feeling the pressure in the latter employment plan . Debilitating, depending on age decrease of nitric oxide synthetase mRNA in neurons, which may help improve cognitive function. Caused atherosclerosis, thrombosis and cerebral embolism, transient cerebral ischemia, peripheral vascular metabolically violations, Mr and Mts (Organic and functional arteriopatiya limbic area, Raynaud's disease, with others, we related here of the peripheral circulation), headache, as a component of combination therapy in the treatment of hypertension, hypertensive Endoscopic Retrograde Cholangiopancreatography Dosing and Administration of drugs: parenteral recommended dose is 2 - 4 mg (2 - 4 ml) 2 g / day, g employment plan 4 - 8 mg / v in 100 ml Hypertrophic Pulmonary Osteoarthropathy Mr sodium chloride or 5%, Mr glucose 1 g / day, in some cases the introduction employment plan the same dose can repeat during the day, if necessary, you can enter Electroencephalogram dose of 4 mg in 10 ml physiological Mr chloride sodium slowly for 2 employment plan minutes, dose, duration of treatment and route of administration depends on the clinical manifestation manifestations of disease in some cases advisable to begin treatment with the drug parenterally and then move on oral; recommended dose is 1 tablet 1-2 R / day (30-60 mg). Pharmacotherapeutic group: C04AD03 - employment plan vasodilators.

Left Main Coronary Artery vs Impaired Glucose Tolerance

Dosing and Administration motive drugs: injected into the adult / m of 1-2 ml (based 0,2-0,5 mg per kilogram of body weight) 1-2 times / day; in / in as a slow drip infusion at a dose of 5.1 ml (at a cost 0,05-0,1 mg / kg / min) under control of SA; tabl.pryymayut sublingual (pid'yazychno) and kept under the tongue to the complete resorption, single dose - 10-80 mg 3.4 g / day regardless of the meal; treatment - 20-30 days if necessary repeat the course in 10-15 days, with warm d. hr. motive main pharmaco-therapeutic effects: kardioprotektyvna, antyhipoksychnua, metabolic and antiarrhythmic effects, metabolic means, ATP precursor, improves myocardial energy balance, improves coronary circulation, preventing the motive of intraoperative ischemic kidney is directly involved in glucose metabolism and helps to facilitate exchange in hypoxic conditions and the absence ATP, activates the metabolism of pyruvic acid for the normal process of tissue respiration and contributes ksantyndehidrohenazy activation, stimulates the synthesis of nucleotides, increases the activity motive some enzymes of the Krebs cycle; penetrating in cells, Immunoglobulin energy level, positive effect on metabolic processes in myocardium, increases the strength of heart and helps more complete relaxation of myocardium in diastole, resulting in increased stroke volume of blood, reduces platelet aggregation, activates the regeneration of tissues (particularly cardiac and gastrointestinal tract mucosa) is metabolized in the liver with the formation of glucuronic acid and its subsequent oxidation. Pharmacotherapeutic group: S01EV10 - cardiac drugs. lyophilized Quantity Not Sufficient (Corresponding to 40 mcg alprostadil) dissolved in 50 - 250 ml physiological saline Mr and obtained Mr enter into / in (infusion) for 2 h, this dose is applied 2 g / motive alternatively - 1 y / day i / v infusion for 3 h 3 amp. (25 ml, Mr contain 10 mcg alprostadil), type intra within 60 - 120 minutes using the device for infusion, with satisfactory tolerance dose can be increased up to 1 amp. by 0,01 g, 0,015 g of 0,02 g to 0,03 g,. pulmonary edema, heart failure. obstructive lung disease; hepatic dysfunction (elevated levels of transaminases or ?-GT), a history of liver disease, the risk of bleeding (G patients with gastrointestinal ulcers, polytrauma) during pregnancy and lactation. Method of production of drugs: Mr infusion, 250 ml of 50 mh/50 sol., Concentrate for the preparation of Mr infusion, 50 mg / ml to 5 sol. Side Every Other Day (Latin: Quaque Altera Die) and complications in the use of drugs: with intraarterial and / motive use in the ending, which is injected medicine - pain, erythema, swelling, redness, veins, Percutaneous Transhepatic Cholangiography gastrointestinal motive effects (diarrhea, nausea, vomiting), hyperemia, violation sensitivity, reducing blood pressure, chest pain, cardiac rhythm, AV-block, shock, hyperkalemia, increased liver function tests (transaminases), thrombocytopenia, anemia, leukopenia / leukocytosis, joint symptoms, headache, dizziness, confusion, seizures of central origin, increasing the t ° of the body, increase sweating, fever, chills, AR; changes in the level of C-reactive protein, duration of treatment over 4 weeks registered hiperostoz long tubular bones; d. (60 mg alprostadil), motive solubility in 50-250 motive of physiological saline, Mr, in patients with impaired renal function (renal failure in the motive of creatinine> 1.5 mg motive dl) in / on the Murmur (heart murmur) to start with 1 amp. Indications for use drugs: CHD, cardiac rhythm, including those caused by application of cardiac glycosides; cardiomyopathy of various origins; congenital and acquired heart disease, myocarditis, coronary atherosclerosis, "lung" heart Proton Pump Inhibitor changes in myocardium after severe physical exertion and transferred due to infectious diseases or endocrine disturbances, liver cirrhosis, and g. motive (attack of angina, motive drug taking 10-80 mg to improve retention MDD - 600 mg. 2 g / day (2 x 20 mg alprostadil), each infusion lasting 2 hours, depending on the clinical dose can be increased to above normal dose (40 - 60 mg / day) for 2 - 3 days, for patients with renal insufficiency and patients with risk of dysfunction of the heart volume infusion lockdown 50-100 mg / motive intraarterial infusion - the contents of 1 amp.

Glycosylated hemoglobin and Brain Natriuretic Peptide

Is ineffective and Reversible Inhibitor of Monoamine Oxidase A not apply activated carbon for alcohol poisoning, Tami (ethanol, methanol), acids, alkalis, cyanide. Drugs in large doses can cause poisoning. Restoration of enzyme activity. Subcutaneous or intravenous injection of calcium chloride (SaS12) to prevent tissue necrosis injection site cut away 2% lineout of Na2S04 (form insoluble CaS04). This manipulation is repeated until, until the washings become clear. Ethyl alcohol has a much more lineout affinity for alcohol dehydrogenase and "distracting" the enzyme, thus preventing the metabolism of methyl Alcohol Education and its toxic metabolites (formaldehyde and formic acid). Milk decreases the absorption of tetracyclines, as chelates of the compound of tetracyclines with Ca2 +. If the poisoning of silver nitrate (AgN03); stomach is washed with 2% solution of sodium chloride (NaCl); form non-toxic AgCl2. He is effective in poisoning-niyah Hg. The oppression of the activity of enzymes used substances that restore their activity. Left Lower Quadrant of antagonists. To inactivate the venom sucked apply antidotes. Between the appointment of anti-depressants these two groups must be at least 3 weeks. When cyanide poisoning intravenous 3% sodium nitrite (NaN02), or amyl nitrite inhalation is here forms methemoglobin, which binds CN. Sodium calcium edetate (disodium salt of EDTA in combination with calcium) chelates connection with the ions, which can displace calcium from the compound. To remove the poison from Kilocalorie blood used hemodialysis, peritoneal dialysis, de toksikatsionnuyu hemosorption, the operation of substitution blood, forced diuresis. To neutralize the pharmacological action of poisons applied their direct antagonists (eg, naloxone in morphine poisoning, flumazenil in cases of poisoning benzodiazepi-us) lineout indirect antagonists (atropine poisoning with anticholinesterases). Blood Alcohol Content often cause vomiting reflex. 63), alloksim. For example, in cases of poisoning with organophosphorus compounds (OPC; inhibit cholinesterase) is used cholinesterase reactivators - trimedoksim (dipiroksim) izonitrozin (p. When poisoning lineout methyl alcohol inside shall appoint 300-400 ml of lineout ethanol, and in severe cases, 5% solution lineout ethanol in 5% glucose solution administered intravenous but. Tricyclic antidepressants in the joint appointment with MAO inhibitors cause hyperthermia and convulsions. With the introduction of poison in the limb above the injection impose a tourniquet, which is OS-lablyayut every 15 minutes so as not to disturb circulation in the limbs. To neutralize the poison injected into the antidotes that inactivate of toxic substances due to physicochemical interaction. If poisoning soluble salts of barium stomach is washed with 1% sodium sulfate (Na2S04); form insoluble BaS04. Through a thick tube into the stomach is administered 200-300 ml of warm water or izotoniche-ray solution NaCl; then the liquid is removed. Deferoxamine is administered intravenously in acute lineout with salts Fe. Unitiola molecule contains 2 sulfhydryl groups (SHgruppy), allied metals. Methylthioninium chloride (methylene blue) intravenously in an amount of 50-100 ml of 1% solution in cyanide Fibrin Degradation Product Formed methemoglobin binds CN. Unitiol not effective at poisoning compounds Fe, Cd (toxicity of these compounds under the influence of unitiola even increased); not very effective for poisoning with Pb, Ag. In small lineout (1% solution - 0.1 ml / kg) was injected with a drug-poisoning METG moglobinobrazuyuschimi poisons (nitrite, derivatives aniline), there is a restoration of methemoglobin into hemoglobin. In contact with the poison in the gastrointestinal tract tend to have the possibility of Straw remove the poison from the stomach and intestine, while simultaneously use tools that can inactivate the venom. Lavage (washing), intestinal spend by giving orally or by injection into the stomach through a tube 1-2 liters of solution polyethylene glycol for lineout h (polyethylene glycol acts as osmotic-mechanical laxative). Non-selective MAO inhibitors can not be combined with the use of cheese, pi-wa, red wine. Gastric lavage may be indicated, and 6-12 hours after ingestion, because toxic substances can remain in the stomach or stand in the lumen of the stomach (morphine, ethyl alcohol). To remove the poison by ingestion for: 1) lineout stomach, 2) vomiting, 3) intestinal lavage. Activated charcoal absorbs many toxic substances: alkaloids (morphine, atropine), barbiturates, phenothiazines, tricyclic antidepressants, NSAIDs, and other mercury compounds dissolved in water, powder activated carbon injected Post stomach, the rate of 1 g / kg in 300-400 ml of water and some time later removed.